Logo

Caliper Announces Plans for 12 Percent Reduction of Workforce and Reorganizes Management Team

Dec 05, 2003

NEW YORK, Dec. 5 (GenomeWeb News) - Caliper Technologies announced today that it is again reducing its workforce, with net reductions adding up to 12 percent of its current workforce - a total of 65 people, including seven at the vice president level - as part of its restructuring plan following it acquisition of Zymark in July.

 

Caliper said in a statement it will also make some hires "to accommodate the move of certain functions to the company's Hopkinton headquarters, and to add skill sets which will support the company's strategic direction."

 

The senior management team has been reorganized, with Anne Kopf-Sill, the current vice president microfluidics R&D becoming vice president molecular diagnostics, and Andrew Chow replacing Kopf-Sill, among other announcements.

 

Caliper said that the latest reconfiguration is focusing on rationalizing R&D resources. The company aims to reach cash-flow breakeven by the end of 2005.

 

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.